Nearly 29,000 bottles of the thyroid-hormone replacement therapy Synthroid are being recalled due to a labeling error in which tablets contain a lower dose of the medication than what is listed on the label. This is the second recall of Synthroid in six months. AbbVie Inc., an Abbott Laboratories spin-off, issued the recall on one lot of 150-microgram Synthroid tablets. The company says the labeling error was due to a manufacturing problem, and it has taken corrective action. AbbVie says it is not aware of any complaints or adverse events associated with the error. In July, three lots of Synthroid ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.